Clinical Impact of a Highly Sensitive Next-Generation Sequencing Measurable Residual Disease Assay in Patients with Acute Lymphoblastic Leukemia
Dissertations and Theses (Open Access)
Part of the Medicine and Health Sciences Commons
Skip to main content